<\/b><\/p>\n
<\/b><\/p>\n
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n
FDA Approves First Artificial Iris<\/font><\/p>\n THURSDAY, May 31, 2018 (HealthDay News) — The first artificial iris has been approved by the U.S. Food and Drug Administration for patients with aniridia.<\/p>\n More Information<\/a><\/p>\n ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care<\/font><\/p>\n THURSDAY, May 31, 2018 (HealthDay News) — The widespread shortages of injectable opioids and small-volume parenteral (SVP) solutions are jeopardizing patient care and placing a strain on hospital operations, according to a report published by the American Society of Health-System Pharmacists (ASHP).<\/p>\n More Information<\/a><\/p>\n Congress Approves Bill Expanding Private Care for VA Patients<\/font><\/p>\n THURSDAY, May 24, 2018 (HealthDay News) — Patients served by the beleaguered Veterans Affairs health system may have wider access to private care, thanks to a bill approved Wednesday by the Senate. President Donald Trump is known to support the bill, which now awaits his signature.<\/p>\n AMA Statement<\/a><\/p>\n More Information<\/a><\/p>\n Global Variation in Personal Health Care Access and Quality<\/font><\/p>\n THURSDAY, May 24, 2018 (HealthDay News) — There is considerable global variation in personal health care access and quality, according to a study published online May 23 in The Lancet<\/i>.<\/p>\n Abstract<\/a><\/p>\n Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n CDC: No Change in Level of Uninsured in U.S. in 2017<\/font><\/p>\n TUESDAY, May 22, 2018 (HealthDay News) — Overall, 9.1 percent of individuals in the United States were uninsured in 2017, which was not significantly different from the level in 2016, according to a report published online May 22 by the U.S. Centers for Disease Control and Prevention’s National Centers for Health Statistics.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Semaglutide Found to Be Effective Against Type 2 Diabetes<\/font><\/p>\n MONDAY, May 21, 2018 (HealthDay News) — Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review published online May 13 in Diabetes, Obesity and Metabolism<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Language Used in Medical Record Can Affect Patient Care<\/font><\/p>\n FRIDAY, May 18, 2018 (HealthDay News) — Stigmatizing language used in medical records to describe patients can influence medical students and residents in terms of their attitudes towards the patient and their clinical decision-making, according to a study published in the May issue of the Journal of General Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Nonprofit Manufacturer Could Keep Generic Drug Costs Down<\/font><\/p>\n WEDNESDAY, May 16, 2018 (HealthDay News) — A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the May 17 issue of the New England Journal of Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Best Practices Developed for Use of EHR to Enhance Patient Care<\/font><\/p>\n WEDNESDAY, May 16, 2018 (HealthDay News) — Best practices have been developed for using electronic health records (EHRs) to enhance patient-centered care, according to an article published online in Medical Economics<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1<\/font><\/p>\n THURSDAY, May 10, 2018 (HealthDay News) — Patients receiving immunotherapy with antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies may develop uveal effusion, according to a report published online April 12 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n FDA Targets Clinics Offering Unapproved Stem Cell Therapies<\/font><\/p>\n THURSDAY, May 10, 2018 (HealthDay News) — The U.S. Food and Drug Administration has launched legal action to stop two stem cell clinics from providing unapproved treatments that have caused serious, long-term harm to some patients.<\/p>\n More Information<\/a><\/p>\n Extended Range of Vision Lens Found Superior to Monofocal<\/font><\/p>\n THURSDAY, May 10, 2018 (HealthDay News) — Extended range of vision (ERV) intraocular lens (IOL) targeted to achieve micro-monovision shows superior range of visual acuity and independence from glasses compared to the monofocal IOL targeted to achieve emmetropia, according to a study published online May 3 in Clinical & Experimental Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Regulatory Requirements Drive Dissatisfaction With EHRs<\/font><\/p>\n TUESDAY, May 8, 2018 (HealthDay News) — Regulatory requirements are likely to be an important aspect of physician dissatisfaction with electronic health records (EHRs) that is driving burnout, according to an Ideas and Opinions piece published online May 8 in the Annals of Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Automated Algorithm Accurately IDs Plus Disease in ROP<\/font><\/p>\n TUESDAY, May 8, 2018 (HealthDay News) — A fully automated algorithm can accurately diagnose plus disease in retinopathy of prematurity (ROP), according to a study published online May 2 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Eyes of Ebola Survivors Show Localized Pathological Changes<\/font><\/p>\n MONDAY, May 7, 2018 (HealthDay News) — Survivors of Ebola virus disease (EVD) have localized pathological changes in photoreceptors, according to a study published online May 3 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Many Organizations Not Meeting Trial Reporting Requirements<\/font><\/p>\n FRIDAY, May 4, 2018 (HealthDay News) — Many organizations are not meeting the trial registration and results reporting requirements clarified by “The Final Rule,” which had a compliance date of April 18, 2017, according to a study published online May 1 in BMC Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Punctal Plug Deemed Beneficial in Ocular Surface Disease<\/font><\/p>\n FRIDAY, May 4, 2018 (HealthDay News) — For patients with ocular surface disease (OSD) using prostaglandin analogue monotherapy, a punctal plug improves OSD and reduces intraocular pressure (IOP), according to a study published online April 26 in Clinical & Experimental Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n In Retinoblastoma Survivors, Oculo-Visual Issues Tied to QoL<\/font><\/p>\n WEDNESDAY, May 2, 2018 (HealthDay News) — Oculo-visual problems among adult retinoblastoma survivors are associated with patient-reported vision-targeted health-related quality of life (HRQoL), according to a study published online April 26 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Practices Should Be Aware of Correct Way to Fire Employees<\/font><\/p>\n TUESDAY, May 1, 2018 (HealthDay News) — Physicians should be aware of the correct protocol for, as well as the laws involved in, firing employees, according to a report published in Medical Economics<\/i>.<\/p>\n